Trial Site Detail

 

Drug:
Imatinib + BYL719
Trial:
A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Dartmouth-Hitchcock Medical Center

     
Lebanon , NH 03756
USA

 

Principal Investigator:
 Lionel Lewis
Contact:
 Nancy Birkrem 603-650-0566 Nancy.P.Birkrem@Dartmouth.edu
Activation Status of this Site:
 Closed
Notes about this Site:
Dartmouth-Hitchcock Medical Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.